Ralliant (NYSE:RAL) Research Coverage Started at BMO Capital Markets

BMO Capital Markets assumed coverage on shares of Ralliant (NYSE:RAL) in a research report released on Monday morning, MarketBeat reports. The brokerage issued a hold rating and a $78.00 price objective on the stock.

Several other brokerages have also commented on RAL. Weiss Ratings reissued a “sell (d)” rating on shares of Ralliant in a research report on Monday, May 4th. TD Cowen increased their price target on shares of Ralliant from $55.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, May 20th. Oppenheimer lifted their price target on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Vertical Research cut shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price objective on the stock. in a report on Wednesday, May 27th. Finally, Morgan Stanley raised their target price on shares of Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a research note on Tuesday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $73.00.

Ralliant Stock Down 1.2%

RAL stock opened at $70.12 on Monday. Ralliant has a fifty-two week low of $37.27 and a fifty-two week high of $75.41. The company has a market capitalization of $7.85 billion and a price-to-earnings ratio of -6.41. The business’s 50 day moving average price is $66.03 and its two-hundred day moving average price is $53.55. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61.

Ralliant (NYSE:RAL) last released its earnings results on Tuesday, May 12th. The company reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.08. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The company had revenue of $534.60 million during the quarter. The business’s revenue was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. As a group, analysts forecast that Ralliant will post 2.64 earnings per share for the current fiscal year.

Ralliant Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 8th were given a $0.05 dividend. The ex-dividend date was Monday, June 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s dividend payout ratio is presently -1.83%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Phocas Financial Corp. grew its holdings in Ralliant by 81.2% during the 4th quarter. Phocas Financial Corp. now owns 157,116 shares of the company’s stock valued at $7,999,000 after buying an additional 70,403 shares in the last quarter. Teacher Retirement System of Texas raised its stake in Ralliant by 6.9% during the fourth quarter. Teacher Retirement System of Texas now owns 570,878 shares of the company’s stock valued at $29,063,000 after purchasing an additional 36,800 shares in the last quarter. Alpha Omega Wealth Management LLC lifted its position in Ralliant by 615.8% during the fourth quarter. Alpha Omega Wealth Management LLC now owns 40,291 shares of the company’s stock valued at $2,051,000 after purchasing an additional 34,662 shares during the last quarter. M&T Bank Corp lifted its position in Ralliant by 464.6% during the fourth quarter. M&T Bank Corp now owns 42,359 shares of the company’s stock valued at $2,156,000 after purchasing an additional 34,857 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH lifted its position in Ralliant by 129.1% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 216,569 shares of the company’s stock valued at $11,054,000 after purchasing an additional 122,039 shares during the last quarter.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.